Clinical Trials Browser

Phase 3 × Has results × osimertinib × Clear all

Carcinoma, Non-Small-Cell Lung

NCT03521154 2026-05-05

LAURA

Phase 3 Active not recruiting

216 enrolled 25 charts 1 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02296125 2026-04-21

FLAURA

Phase 3 Completed

674 enrolled 21 charts 1 FDA

Thoracic

Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer

NCT04765059 2026-04-21

COMPEL

Phase 3 Active not recruiting

98 enrolled 14 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT02511106 2026-03-30

ADAURA

Phase 3 Active not recruiting

682 enrolled 20 charts 1 FDA

Thoracic

Stage IB-IIIA Non-small Cell Lung Carcinoma

NCT02411448 2026-01-16

RELAY

Phase 3 Active not recruiting

545 enrolled 24 charts 1 FDA

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04035486 2025-10-10

FLAURA2

Phase 3 Active not recruiting

587 enrolled 44 charts 1 FDA

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

NCT02151981 2025-01-07

AURA3

Phase 3 Completed

421 enrolled 18 charts

Anticancer Treatment

NCT02454933 2024-09-19

CAURAL

Phase 3 Completed

29 enrolled 10 charts

Thoracic

Locally Advanced or Metastatic EGFR T790M+ NSCLC

NCT05493501 2024-05-02

Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer

Phase 3 Terminated

8 enrolled 7 charts

Thoracic

NSCLC

NCT04816214 2024-03-05

GEOMETRY-E

Phase 3 Terminated

6 enrolled 20 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Clinical Trials

MARIPOSA

LAURA

FLAURA

COMPEL

ADAURA

RELAY

FLAURA2

AURA3

CAURAL

Aumolertinib With Chemotherapy or Alone Compared With Osimertinib in Patients With Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer

GEOMETRY-E